GLENMARK PHARMACEUTICALS EUROPE R&D LIMITED
HARROW GLENMARK PHARMACEUTICALS EUROPE LIMITED NEWINCCO 778 LIMITED

Hellopages » Greater London » Brent » HA3 0BU
Company number 06420547
Status Active
Incorporation Date 7 November 2007
Company Type Private Limited Company
Address LAXMI HOUSE 2-B DRAYCOTT AVENUE, KENTON, HARROW, MIDDLESEX, HA3 0BU
Home Country United Kingdom
Nature of Business 72110 - Research and experimental development on biotechnology
Phone, email, etc

Since the company registration eighty-five events have happened. The last three records are Confirmation statement made on 31 January 2017 with updates; Full accounts made up to 31 March 2016; Confirmation statement made on 7 November 2016 with updates. The most likely internet sites of GLENMARK PHARMACEUTICALS EUROPE R&D LIMITED are www.glenmarkpharmaceuticalseuroperd.co.uk, and www.glenmark-pharmaceuticals-europe-r-d.co.uk. The predicted number of employees is 1 to 10. The company’s age is eighteen years and three months. Glenmark Pharmaceuticals Europe R D Limited is a Private Limited Company. The company registration number is 06420547. Glenmark Pharmaceuticals Europe R D Limited has been working since 07 November 2007. The present status of the company is Active. The registered address of Glenmark Pharmaceuticals Europe R D Limited is Laxmi House 2 B Draycott Avenue Kenton Harrow Middlesex Ha3 0bu. . BOURNE, Oliver Henry is a Director of the company. PINTO, Cheryl is a Director of the company. VANJARI, Meera Nilesh is a Director of the company. Secretary LAXMI FINANCIAL SERVICES LIMITED has been resigned. Secretary OLSWANG COSEC LIMITED has been resigned. Director CLARK, Guy Hedley has been resigned. Director EFTHIMIOU, John, Dr has been resigned. Director KEOHANE, Patrick Peter, Dr has been resigned. Director LIVESEY, Ewan Murray has been resigned. Director MENDONZA, Marshall Joseph has been resigned. Director SALDANHA, Glenn Mario has been resigned. Nominee Director OLSWANG DIRECTORS 1 LIMITED has been resigned. Nominee Director OLSWANG DIRECTORS 2 LIMITED has been resigned. The company operates in "Research and experimental development on biotechnology".


Current Directors

Director
BOURNE, Oliver Henry
Appointed Date: 20 August 2015
45 years old

Director
PINTO, Cheryl
Appointed Date: 03 December 2007
59 years old

Director
VANJARI, Meera Nilesh
Appointed Date: 08 May 2013
51 years old

Resigned Directors

Secretary
LAXMI FINANCIAL SERVICES LIMITED
Resigned: 14 March 2012
Appointed Date: 03 December 2007

Secretary
OLSWANG COSEC LIMITED
Resigned: 03 December 2007
Appointed Date: 07 November 2007

Director
CLARK, Guy Hedley
Resigned: 10 November 2008
Appointed Date: 03 December 2007
56 years old

Director
EFTHIMIOU, John, Dr
Resigned: 30 November 2009
Appointed Date: 03 November 2008
72 years old

Director
KEOHANE, Patrick Peter, Dr
Resigned: 31 December 2015
Appointed Date: 15 March 2015
71 years old

Director
LIVESEY, Ewan Murray
Resigned: 23 August 2010
Appointed Date: 03 November 2008
57 years old

Director
MENDONZA, Marshall Joseph
Resigned: 08 May 2013
Appointed Date: 02 June 2009
70 years old

Director
SALDANHA, Glenn Mario
Resigned: 02 June 2009
Appointed Date: 03 December 2007
56 years old

Nominee Director
OLSWANG DIRECTORS 1 LIMITED
Resigned: 03 December 2007
Appointed Date: 07 November 2007

Nominee Director
OLSWANG DIRECTORS 2 LIMITED
Resigned: 03 December 2007
Appointed Date: 07 November 2007

Persons With Significant Control

Ms Blanche Elizabeth Saldanha
Notified on: 6 April 2016
85 years old
Nature of control: Ownership of shares – More than 25% but not more than 50% as a trustee of a trust

Mrs Cherylann Pinto
Notified on: 6 April 2016
59 years old
Nature of control: Ownership of shares – More than 25% but not more than 50% as a trustee of a trust

Mr Glenn Saldanha
Notified on: 6 April 2016
56 years old
Nature of control: Ownership of shares – More than 25% but not more than 50% as a trustee of a trust

GLENMARK PHARMACEUTICALS EUROPE R&D LIMITED Events

23 Feb 2017
Confirmation statement made on 31 January 2017 with updates
14 Dec 2016
Full accounts made up to 31 March 2016
21 Nov 2016
Confirmation statement made on 7 November 2016 with updates
10 Feb 2016
Termination of appointment of Patrick Peter Keohane as a director on 31 December 2015
24 Nov 2015
Annual return made up to 7 November 2015 with full list of shareholders
Statement of capital on 2015-11-24
  • GBP 800,708

...
... and 75 more events
10 Dec 2007
New director appointed
10 Dec 2007
Director resigned
10 Dec 2007
Secretary resigned
10 Dec 2007
Director resigned
07 Nov 2007
Incorporation